SCHEMBL4788652

SCHEMBL4788652

CC[C@@H](CO)Nc1cnc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 6/20 0.52
FYN P06241 5/20 0.50
CRHR1 P34998 1/20 0.50
DYRK3 O43781 5/20 0.44
CCNT1 O60563 5/20 0.44
CDK9 P50750 5/20 0.44
CDK5 Q00535 5/20 0.44
DYRK1A Q13627 5/20 0.44
CDK5R1 Q15078 5/20 0.44
DYRK2 Q92630 5/20 0.44
DYRK1B Q9Y463 5/20 0.44
KDM4E B2RXH2 2/20 0.43
NPC1 O15118 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCNA2 P20248 4/20 0.43
CDK2 P24941 4/20 0.43
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14545539 0.92 CRHR1 (0.57) CNR1FYNCRHR1
SCHEMBL14544920 0.85 CRHR1 (0.48) CNR1FYNCRHR1HPGDMEN1
SCHEMBL14544910 0.74 MEN1 (0.43) CNR1CRHR1KDM4ENPC1HPGD
SCHEMBL102984 0.72 FYN (0.79) FYNDYRK3CCNT1CDK9CDK5
SCHEMBL102963 0.71 PIM1 (0.58) FYNKDM4ENPC1HPGDRAB9A
SCHEMBL17604111 0.70 HTT (0.47) CNR1CRHR1DYRK3CCNT1CDK9
SCHEMBL15864503 0.70 FYN (0.58) FYNCRHR1DYRK3CCNT1CDK9
SCHEMBL19692970 0.69 FYN (0.44) FYNDYRK3CCNT1CDK9CDK5
SCHEMBL21378510 0.69 FYN (0.44) FYNDYRK3CCNT1CDK9CDK5
SCHEMBL30085635 0.69 DYRK1A (0.48) FYNDYRK3CCNT1CDK9CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008132162-A1 3- (SULPHONYLAMINO) -PHENYL-2 -HYDROXY-ETHYLAMINO DERIVATIVES USEFUL AS BETA-AGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS MEDICAMENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-11-06 WO disclosed
EP-1871762-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2008-01-02 EP disclosed
WO-2006113704-A2 SUBTITUTED HETEROARYL CB1 ANTAGONISTS NEUROGEN CORPORATION (US) 2006-10-26 WO disclosed